(Q40841076)

24 September 2017

1 reference

title

Leukotriene antagonists and inhibitors as modulators of IgE-mediated reactions (English)

1 reference

24 September 2017

A W Ford-Hutchinson

1

1 reference

24 September 2017

language of work or name

1 reference

1 January 1993

1 reference

Seminars in Immunopathology

24 September 2017

published in

1 reference

24 September 2017

volume

15

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

37-50

1 reference

Characterization of a 5-lipoxygenase-activating protein binding assay: correlation of affinity for 5-lipoxygenase-activating protein with leukotriene synthesis inhibition

24 September 2017

cites work

1 reference

12 December 2020

Heterogeneity of human polymorphonuclear leukocyte receptors for leukotriene B4. Identification of a subset of high affinity receptors that transduce the chemotactic response

1 reference

12 December 2020

Human T-lymphocyte subset specificity of the regulatory effects of leukotriene B4

1 reference

12 December 2020

Leukotriene B4 in inflammation.

1 reference

12 December 2020

Inhibition of human leukocyte 5-lipoxygenase by a 4-hydroxybenzofuran, L-656,224. Evidence for enzyme reduction and inhibitor degradation

1 reference

12 December 2020

Leukotrienes: potent mediators of airway constriction.

1 reference

12 December 2020

Inhibition of endogenous leukotriene-mediated lung anaphylaxis in guinea pigs by a novel receptor antagonist ONO-1078.

1 reference

12 December 2020

Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist

1 reference

12 December 2020

L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2 - dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor

1 reference

12 December 2020

Maximal airway narrowing to inhaled leukotriene D4 in normal subjects. Comparison and interaction with methacholine

1 reference

12 December 2020

The effect of an oral leukotriene antagonist L-649,923 on histamine and leukotriene D4-induced bronchoconstriction in normal man.

1 reference

12 December 2020

L-649,923, sodium (beta S*, gamma R*)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propylthio)- gamma-hydroxy-beta-methylbenzenebutanoate, a selective, orally active leukotriene receptor antagonist

1 reference

12 December 2020

Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis

1 reference

12 December 2020

Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responses

1 reference

12 December 2020

Reduced Allergen-Induced Nasal Congestion and Leukotriene Synthesis with an Orally Active 5-Lipoxygenase Inhibitor

1 reference

12 December 2020

5-lipoxygenase inhibitory activity of zileuton

1 reference

12 December 2020

Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist

1 reference

12 December 2020

Liberation of histamine and formation of lysocithin-like substances by cobra venom

1 reference

12 December 2020

Structure of slow-reacting substance of anaphylaxis from guinea-pig lung

1 reference

12 December 2020

Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist

1 reference

12 December 2020

The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air

1 reference

12 December 2020

L-648,051, sodium 4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)- propylsulfonyl]-gamma-oxo-benzenebutanoate: a leukotriene D4 receptor antagonist.

1 reference

12 December 2020

Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma

1 reference

12 December 2020

Identification and isolation of a membrane protein necessary for leukotriene production

1 reference

12 December 2020

Inhibition of leukotriene C and leukotriene D biosynthesis

1 reference

12 December 2020

Human leukotriene C4 synthase expression in dimethyl sulfoxide-differentiated U937 cells

1 reference

12 December 2020

The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist

1 reference

12 December 2020

A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP

1 reference

12 December 2020

MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes

1 reference

12 December 2020

The effect of an inhaled leukotriene antagonist, L-648,051, on early and late asthmatic reactions and subsequent increase in airway responsiveness in man

1 reference

12 December 2020

Human 5-lipoxygenase contains an essential iron

1 reference

12 December 2020

The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs).

1 reference

12 December 2020

MK-571, a potent antagonist of leukotriene D4-induced bronchoconstriction in the human.

1 reference

12 December 2020

Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes

1 reference

12 December 2020

The effects of inhaled leukotriene E4 on the airway responsiveness to histamine in subjects with asthma and normal subjects

1 reference

12 December 2020

Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma

1 reference

12 December 2020

Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects

1 reference

12 December 2020

Leukotriene receptor antagonists as potential therapeutic agents

1 reference

12 December 2020

Pseudoperoxidase activity of 5-lipoxygenase stimulated by potent benzofuranol and N-hydroxyurea inhibitors of the lipoxygenase reaction

1 reference

12 December 2020

Purification of human leukotriene C4 synthase from dimethylsulfoxide-differentiated U937 cells

1 reference

12 December 2020

FLAP: a novel drug target for inhibiting the synthesis of leukotrienes

1 reference

12 December 2020

Leukotriene B: a potential mediator of inflammation

1 reference

12 December 2020

Leukotriene C: a slow-reacting substance from murine mastocytoma cells

1 reference

12 December 2020

Leukotriene B4 potentiates the expression and release of Fc epsilon RII/CD23, and proliferation and differentiation of human B lymphocytes induced by IL-4

1 reference

12 December 2020

Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)- indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitor

1 reference

12 December 2020

Specific binding of leukotriene B4 to receptors on human polymorphonuclear leukocytes

1 reference

12 December 2020

Evaluation of the role of conserved His and Met residues among lipoxygenases by site-directed mutagenesis of recombinant human 5-lipoxygenase

1 reference

12 December 2020

Pharmacology of the leukotriene antagonist verlukast: the (R)-enantiomer of MK-571

1 reference

12 December 2020

Leukotriene B4 induces human suppressor lymphocytes

1 reference

12 December 2020

Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients

1 reference

12 December 2020

Methoxytetrahydropyrans. A new series of selective and orally potent 5-lipoxygenase inhibitors

1 reference

12 December 2020

Leukotriene B4 enhances activation, proliferation, and differentiation of human B lymphocytes

1 reference

12 December 2020

The effect of an oral leukotriene D4 antagonist L-649,923 on the response to inhaled antigen in asthma.

1 reference

12 December 2020

Identification of a human gamma-glutamyl cleaving enzyme related to, but distinct from, gamma-glutamyl transpeptidase

1 reference

12 December 2020

Leukotriene A3. A poor substrate but a potent inhibitor of rat and human neutrophil leukotriene A4 hydrolase

1 reference

12 December 2020

Leukotriene D: a slow reacting substance from rat basophilic leukemia cells

1 reference

12 December 2020

Molecular cloning of a cDNA coding for human leukotriene A4 hydrolase. Complete primary structure of an enzyme involved in eicosanoid synthesis.

1 reference

12 December 2020

Inhibition of leukotriene D4-induced bronchoconstriction in normal subjects by the oral LTD4 receptor antagonist ICI 204,219.

1 reference

12 December 2020

A specific LTD4/LTE4-receptor antagonist improves pulmonary function in patients with mild, chronic asthma

1 reference

12 December 2020

5-Lipoxygenase-activating protein is the target of a novel hybrid of two classes of leukotriene biosynthesis inhibitors

1 reference

12 December 2020

Slow reacting substance and related compounds

1 reference

12 December 2020

Effect of RG 12525, an oral leukotriene D4 antagonist, on the airway response to inhaled leukotriene D4 in subjects with mild asthma

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00204625

1 reference

24 September 2017

1 reference